Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing
On January 13, 2023, Arbor Rapha Capital Bioholdings Corp. I (the "Company")
received a letter from the Listing Qualifications Staff (the "Staff') of the
Nasdaq Stock Market LLC ("Nasdaq"), which stated that the Company was not in
compliance with the requirements of Nasdaq Listing Rules (i) 5450(b)(2)(B),
requiring a minimum of $50 million Market Value of Listed Securities requirement
(the "Market Value Requirement"); (ii) 5450(b)(2)(A), requiring a minimum
1,100,000 Publicly Held Shares (the "Publicly Held Shares Requirement"), and
(iii) 5450(b)(2)(C), requiring a minimum of $15 million Market Value of Publicly
Held Shares requirement (the "Market Value of Publicly Held Shares
Requirement"). Additionally, while companies are normally afforded compliance
periods or the ability to submit a plan of compliance in order to be granted
time to regain compliance, the Staff has determined to apply a more stringent
criteria as permitted under Nasdaq Listing Rule 5101 to delist the Company's
Securities (as defined below) from The Nasdaq Global Market. In addition, on
January 12, 2023, Nasdaq determined to halt trading in the Company's Securities.
The Staff's determination to delist the Company's Class A common stock, warrants
and units (collectively, the "Securities") is based on the fact that in
connection with the Company's previously announced special meeting, held on
December 8, 2022, the Company's stockholders elected to redeem an aggregate of
17,188,668 shares of Class A common stock, representing approximately 99.6% of
the issued and outstanding Class A common stock. As such, the Staff determined
that the Company no longer complies with: (i) Market Value Requirement; (ii)
Publicly Held Shares Requirement; and (iii) Market Value of Publicly Held Shares
Requirement. Additionally, the Staff noted that the Company does not comply with
either of the alternatives requirements for continued listing on the Nasdaq
Global Market under Nasdaq Listing Rules 5450(b)(1) or 5450(b)(3), or the
requirement for continued listing on the Nasdaq Capital Market under Nasdaq
Listing Rule 5550.
Accordingly, the Company expects its Securities to be delisted effective with
the open of business on January 24, 2023. The Company anticipates that its
Securities may be traded over-the-counter following the suspension in trading of
its Securities on Nasdaq.
Item 7.01 Regulation FD Disclosure.
As required under Nasdaq rules, the Company issued a press release on January
18, 2023, announcing Nasdaq's letter, a copy of which is furnished herewith as
Exhibit 99.1 and is incorporated herein by reference.
The information in this Item 7.01, including Exhibit 99.1, is furnished and
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
liabilities under that section, and shall not be deemed to be incorporated by
reference into the filings of the Company under the Securities Act or the
Exchange Act, regardless of any general incorporation language in such filings.
This Current Report on Form 8-K will not be deemed an admission as to the
materiality of any information of the information contained in this Item 7.01,
including Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press Release, dated January 18, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
1
© Edgar Online, source Glimpses